BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-03-31
• Last 15 days FTD volume: $2.67 M
• Last 3 months FTD volume: $3.95 M
• Last 12 months FTD volume: $8.45 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$31.57 M	$0.12 B	🇺🇸 USA
GSK plc GSK	$18.15 M	$0.23 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$4.14 M	$23.87 M	🇺🇸 USA
Repligen RGEN	$8.1 M	$20.27 M	🇺🇸 USA
Novavax NVAX	$12.4 M	$65.68 M	🇺🇸 USA
Celldex Therapeutics CLDX	$1.57 M	$11.14 M	🇺🇸 USA
NanoViricides NNVC	$0.01 M	$4.06 M	🇺🇸 USA
Cel-Sci CVM	N/A	$0.1 M	🇺🇸 USA
Emergent BioSolutions EBS	$0.23 M	$3.64 M	🇺🇸 USA